SUNPHARMA NSE filing

Scheme of Arrangement Effective Date

The RealCase readMedium impact Positive

Sun Pharma announces that the Composite Scheme of Arrangement has been sanctioned by NCLT and is effective from November 22, 2025, following the filing of the order copy with the Registrar of Companies.

Why it matters

The Scheme of Arrangement becoming effective is a significant corporate action that can influence the company's structure and operations.

The market read

The announcement confirms the successful completion of the Scheme of Arrangement, which is generally viewed positively.

* The Composite Scheme of Arrangement has been sanctioned by the National Company Law Tribunal. * The certified copy of the order has been filed with the Registrar of Companies on 22 November 2025. * The scheme is effective from 22 November 2025. * All directions given under the order have been complied with.

Filing to action

What to do with a filing like this

Sun Pharmaceutical Industries Limited filed this with the NSE as a statutory disclosure, categorised under merger. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Sun Pharmaceutical Industries Limited. Read the original for the full detail.

View original filing